French Study: Vitamin D3 Reduces Activity of MS in Early Stages
Doha: A French study has revealed that taking vitamin D3 (cholecalciferol) orally at a dose of 100,000 international units every two weeks may significantly reduce multiple sclerosis (MS) activity in patients with clinically isolated syndrome (CIS) an…